246 related articles for article (PubMed ID: 30184328)
1. In vitro evaluation of anti-fibrotic effects of select cytokines for vocal fold scar treatment.
Chen H; Erndt-Marino J; Diaz-Rodriguez P; Kulwatno J; Jimenez-Vergara AC; Thibeault SL; Hahn MS
J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1056-1067. PubMed ID: 30184328
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of a basic fibroblast growth factor-containing hydrogel toward vocal fold lamina propria scar treatment.
Erndt-Marino JD; Jimenez-Vergara AC; Diaz-Rodriguez P; Kulwatno J; Diaz-Quiroz JF; Thibeault S; Hahn MS
J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1258-1267. PubMed ID: 28580765
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
[TBL] [Abstract][Full Text] [Related]
4. Modeling fibrosis using fibroblasts isolated from scarred rat vocal folds.
Kishimoto Y; Kishimoto AO; Ye S; Kendziorski C; Welham NV
Lab Invest; 2016 Jul; 96(7):807-16. PubMed ID: 27111284
[TBL] [Abstract][Full Text] [Related]
5. Influence of hydrogel mechanical properties and mesh size on vocal fold fibroblast extracellular matrix production and phenotype.
Liao H; Munoz-Pinto D; Qu X; Hou Y; Grunlan MA; Hahn MS
Acta Biomater; 2008 Sep; 4(5):1161-71. PubMed ID: 18515199
[TBL] [Abstract][Full Text] [Related]
6. A tissue-specific, injectable acellular gel for the treatment of chronic vocal fold scarring.
Xu CC; Mau T
Acta Biomater; 2019 Nov; 99():141-153. PubMed ID: 31425889
[TBL] [Abstract][Full Text] [Related]
7. Vocal fold fibroblasts immunoregulate activated macrophage phenotype.
King SN; Chen F; Jetté ME; Thibeault SL
Cytokine; 2013 Jan; 61(1):228-36. PubMed ID: 23123198
[TBL] [Abstract][Full Text] [Related]
8. Towards an in vitro fibrogenesis model of human vocal fold scarring.
Graupp M; Rinner B; Frisch MT; Weiss G; Fuchs J; Sundl M; El-Heliebi A; Moser G; Kamolz LP; Karbiener M; Gugatschka M
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1211-1218. PubMed ID: 29520499
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor and its receptor c-met in rat and rabbit vocal folds.
Hirano S; Thibeault S; Bless DM; Ford CN; Kanemaru S
Ann Otol Rhinol Laryngol; 2002 Aug; 111(8):661-6. PubMed ID: 12184584
[TBL] [Abstract][Full Text] [Related]
10. Influence of glycosaminoglycan identity on vocal fold fibroblast behavior.
Jimenez-Vergara AC; Munoz-Pinto DJ; Becerra-Bayona S; Wang B; Iacob A; Hahn MS
Acta Biomater; 2011 Nov; 7(11):3964-72. PubMed ID: 21740987
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of types I and III collagen in tunable hyaluronan hydrogels for vocal fold tissue engineering.
Walimbe T; Calve S; Panitch A; Sivasankar MP
Acta Biomater; 2019 Mar; 87():97-107. PubMed ID: 30708064
[TBL] [Abstract][Full Text] [Related]
12. Vocal fold fibroblast response to growth factor treatment is age dependent: results from an in vitro study.
Graupp M; Kiesler K; Friedrich G; Ainödhofer H; Gruber HJ; Kieslinger P; Saxena A; Hirano S; Gugatschka M
J Voice; 2014 Jul; 28(4):420-3. PubMed ID: 24495429
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cytokines in Modulating Vocal Fold Fibrosis: A Contemporary Review.
Xu H; Fan GK
Laryngoscope; 2021 Jan; 131(1):139-145. PubMed ID: 32293731
[TBL] [Abstract][Full Text] [Related]
14. Cell-cell interaction between vocal fold fibroblasts and bone marrow mesenchymal stromal cells in three-dimensional hyaluronan hydrogel.
Chen X; Thibeault SL
J Tissue Eng Regen Med; 2016 May; 10(5):437-46. PubMed ID: 23653427
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomics of paired vocal fold and oral mucosa fibroblasts.
Karbiener M; Darnhofer B; Frisch MT; Rinner B; Birner-Gruenberger R; Gugatschka M
J Proteomics; 2017 Feb; 155():11-21. PubMed ID: 28099887
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of immortalized human vocal fold fibroblast cell lines.
Chu Y; Fang Y; Wu H; Cheng L; Chen J
Biotechnol Lett; 2023 Mar; 45(3):347-355. PubMed ID: 36650343
[TBL] [Abstract][Full Text] [Related]
17. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.
Kishimoto Y; Hirano S; Kitani Y; Suehiro A; Umeda H; Tateya I; Kanemaru S; Tabata Y; Ito J
Laryngoscope; 2010 Jan; 120(1):108-13. PubMed ID: 19877197
[TBL] [Abstract][Full Text] [Related]
18. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
[TBL] [Abstract][Full Text] [Related]
19. Pulsed dye laser-induced inflammatory response and extracellular matrix turnover in rat vocal folds and vocal fold fibroblasts.
Lin Y; Yamashita M; Zhang J; Ling C; Welham NV
Lasers Surg Med; 2009 Oct; 41(8):585-94. PubMed ID: 19746432
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery system of basic fibroblast growth factor using gelatin hydrogel for restoration of acute vocal fold scar.
Kobayashi T; Mizuta M; Hiwatashi N; Kishimoto Y; Nakamura T; Kanemaru SI; Hirano S
Auris Nasus Larynx; 2017 Feb; 44(1):86-92. PubMed ID: 27126068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
